SCHEMBL1128591

SCHEMBL1128591

Clc1cnn(C2CCCCO2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 1/20 0.40
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
YTHDC1 Q96MU7 1/20 0.36
CYP4F2 P78329 3/20 0.35
CYP4A11 Q02928 3/20 0.35
CYP1A2 P05177 1/20 0.34
TSHR P16473 1/20 0.34
FLT3 P36888 2/20 0.33
SYK P43405 1/20 0.33
AURKB Q96GD4 1/20 0.33
CYP2C19 P33261 1/20 0.33
MCL1 Q07820 1/20 0.33
FGFR1 P11362 2/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
KDR P35968 1/20 0.33
RXRA P19793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17714250 0.80 CYP4F2 (0.43) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL584036 0.80 KDM5B (0.40) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL15607370 0.80 KDM5B (0.40) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL20237038 0.80 KDM5B (0.40) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL12552172 0.80 MPO (0.43) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL20380105 0.80 KDM5B (0.40) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL1565909 0.80 KDM5B (0.42) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL16353569 0.80 ALDH1A1 (0.44) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL21962281 0.80 CYP4F2 (0.40) KDM5BALDH1A1LMNAPOLBYTHDC1
SCHEMBL22774288 0.80 KDM5B (0.40) KDM5BALDH1A1LMNAPOLBYTHDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022231242-A1 INDAZOLE COMPOUND HAVING LRRK2 INHIBITORY ACTIVITY 주식회사 스탠다임 2022-11-03 WO disclosed
CN-108884050-B Tetrahydroisoquinoline derivatives UCB生物制药私人有限公司 2022-07-05 CN disclosed
EP-3152213-B1 DIFLUOROETHYLPYRIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS RUGEN HOLDINGS CAYMAN LTD (KY) 2018-10-31 EP disclosed
EP-3152213-A1 DIFLUOROETHYLPYRIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS Rugen Holdings (Cayman) Limited (KY) 2017-04-12 EP disclosed
WO-2015187845-A1 DIFLUOROETHYLPYRIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS RUGEN HOLDINGS (CAYMAN) LIMITED (KY) 2015-12-10 WO disclosed
EP-2283019-A1 GPR119 RECEPTOR AGONISTS F. Hoffmann-La Roche AG (CH) 2011-02-16 EP disclosed
WO-2009141238-A1 GPR119 RECEPTOR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-11-26 WO disclosed
CN-1036766-A 4-substituted pyrazolecarboxylic [3,4-d] pyrimidine derivatives ORTHO PHARMA CORP (US) 1989-11-01 CN disclosed